Predictors of clinically significant disease on systematic cores only in magnetic resonance imaging-guided prostate biopsy

Predictors of clinically significant disease on systematic cores only in magnetic resonance imaging-guided prostate biopsy

Bibliographic Details
Main Authors:	A. Kalapara, N.J. Sathianathen, C.A. Warlick, C.J. Weight, B. Spilseth, P. Murugan, M.A. Ordonez, J. Zabell, B.R. Konety
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320336302

Similar Items

Predictors of negative targeted prostate biopsy despite PIRADS 4-5 lesions on multiparametric magnetic resonance imaging
by: A. Kalapara, et al.
Published: (2020-07-01)

The current status of immunobased therapies for metastatic renal-cell carcinoma
by: Sathianathen NJ, et al.
Published: (2017-12-01)

The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
by: Niranjan J. Sathianathen, et al.
Published: (2018-09-01)

Predictors of erectile dysfunction after transperineal template prostate biopsy
by: J-L. Tan, et al.
Published: (2020-07-01)

4159 Prostate cancer multiparametric MRI comparison study of 3T versus 7T in terms of lesion detection and image quality
by: Ethan Leng, et al.
Published: (2020-06-01)

A low cost solution for post-biopsy complications using available RFA generator and coaxial core biopsy needle
by: Azlan, C.A., et al.
Published: (2007)

Histopathologic Review of Previously Negative Prostatic Core Needle Biopsies following a New Diagnosis of Adenocarcinoma of the Prostate by Core Needle Biopsies: Implications for Quality Assurance Programs
by: Jay Patel, et al.
Published: (2008-01-01)

An international challenge to use artificial intelligence to define the state of the art in kidney and kidney tumor segmentation in CT imaging
by: N. Heller, et al.
Published: (2020-07-01)

What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?
by: Gokhan Sonmez, et al.
Published: (2020-09-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Clinical Value of Core Lenght in Saturation Prostate Biopsy
by: Cem Yücel, et al.
Published: (2018-06-01)

Determining the feasibility of transperineal prostate biopsies under conscious sedation: A single-centre pilot study
by: A.T. Looney, et al.
Published: (2020-09-01)

Clinical value of core length in contemporary multicore prostate biopsy.
by: Sangchul Lee, et al.
Published: (2015-01-01)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
by: Nicolette G. Alkema, et al.
Published: (2022-10-01)

Retrospective study comparing six - and twelve-core prostate biopsy in detection of prostate cancer
by: Motoi Tobiume, et al.
Published: (2008-02-01)

Comparing the Diagnostic Performance of Micro- Ultrasound-Guided Biopsy Versus Multiparametric Magnetic Resonance Imaging-Targeted Biopsy in the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-Analysis
by: Finín Cotter, et al.
Published: (2023-11-01)

FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY
by: A. A. Keln, et al.
Published: (2018-01-01)

Intraoperative fluorescence confocal microscopy of targeted biopsy cores for real time diagnosis of prostate cancer. Initial experience and results
by: J.L. Marenco, et al.
Published: (2020-07-01)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
by: Sangjun Yoo, et al.
Published: (2020-06-01)

Disseminated carcinomatosis of the bone marrow caused by prostate cancer diagnosed with only bone marrow biopsy
by: Takahito Wakamiya, et al.
Published: (2021-09-01)

Sagittal alignment in an MR-TRUS fusion biopsy using only the prostate contour in the axial image
by: Riki Igarasihi, et al.
Published: (2020-01-01)

MRI-guided core needle biopsy of the prostate: acceptance and side effects
by: Nina Egbers, et al.
Published: (2015-05-01)

Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
by: Renato Caretta Chambó, et al.
Published: (2015-02-01)

Repeated biopsy in the detection of prostate cancer: When and how many cores
by: Vincenzo Scattoni, et al.
Published: (2014-12-01)

Importance of Malignant Core Length in the Detection of Clinically Significant Prostate Cancer in Transrectal Prostate Biopsies
by: Gökçe Dündar, et al.
Published: (2023-06-01)

Concordance of MRI-Guided Fusion and Systematic 12-Core Prostate Biopsy for the Detection of Prostate Cancer
by: Matthew Parsons, et al.
Published: (2022-05-01)

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
by: Benedikt Hoeh, et al.
Published: (2022-03-01)

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital
by: Leonor J. Paulino Pereira, et al.
Published: (2023-09-01)

Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists
by: Jaudah Ahmed Al-Maghrabi, et al.
Published: (2013-01-01)

Radical prostatectomy (RP) findings in cases with only intraductal carcinoma of the prostate (IDC-P) on needle biopsy
by: Athanase Billis
Published: (2010-04-01)

The diagnostic ability of an additional midline peripheral zone biopsy in transrectal ultrasonography-guided 12-core prostate biopsy to detect midline prostate cancer
by: Inpyeong Hwang, et al.
Published: (2016-01-01)

Complications of Transrectal Prostate Biopsy
by: Cech P., et al.
Published: (2014-05-01)

Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin
by: Pawan Vasudeva, et al.
Published: (2015-12-01)

MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men
by: Vidhush K. Yarlagadda, et al.
Published: (2018-05-01)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
by: Thiago N. Valette, et al.
Published: (2015-06-01)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
by: Avery, K, et al.
Published: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
by: Avery, K, et al.
Published: (2012)

Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
by: Yasushi Nakai, et al.
Published: (2017-04-01)

Clinicopathological Study of Prostatic Biopsies
by: A.JOSEPHINE
Published: (2014-09-01)

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?
by: Berridge, C, et al.
Published: (2024)